For LatinX and Hispanic people burdened by COVID disease, where can they go for hope? An early pre-print of our report is now available here. What do we already know? Access to and patient enrollment in clinical trials of COVID-19 therapies is likely strongly impacted by where trials are launched. Our objectives were to evaluate … Continue reading LatinX Inequity: Access to COVID Treatment Trials
Will HIV vaccines compete with existing HIV prevention strategies? Who is doing COVID vaccine cost-effectiveness analysis? Fred Hutch Science Spotlight translated the math in our peer-reviewed paper published in the Journal of the International AIDS Society to explain the economic tradeoffs of delivering an HIV vaccine in Seattle in the future. Our prior review of … Continue reading Lessons from cost-effectiveness of HIV vaccines for COVID vaccines
COVID-19 disparities persist in our most vulnerable communities, including low-income families and racial and ethnic minorities, partly because of the financial necessity to continue working, as well as the lack of employment opportunities that enable their residents to work remotely. They are more likely to be essential workers, and that increases their exposure to the … Continue reading Economic roots of COVID-19 racial disparities
Pulled from the Infectious Economics archives, these articles provide recommendations for the design and development of robust mathematical models of COVID-19 epidemiology and economics to reduce uncertainty in decision-making and inform evidence-based public policy. Associations are easy; valid causal inference is hard Tutorial: how to estimate person-centered treatment effects so that public policy to control … Continue reading Advanced methods for math modeling the epidemiology and economics of coronavirus
